Furthermore, a genome-wide association study (GWAS) identified TSLP as a susceptibility gene in EGPA, lending pathophysiologic credibility to TSLP inhibition (9). The gene discussed is TSLP; the disease is eosinophilic granulomatosis with polyangiitis.